🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase III double-masked, randomized, controlled study evaluating ...
Status
Completed
Location
Investigational Site
Start Date
2014-01
Trial ID
NCT01998802
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of 84 successive days...
Status
Completed
Location
Contact Alcon Call Center for Trial Locations
Start Date
2015-03-03
Trial ID
NCT02355028
Treatments Being Tested
The objective of this study is to evaluate the chronic safety and effective...
Status
Completed
Location
Mexico City
Start Date
2019-02-18
Trial ID
NCT03873246
Treatments Being Tested
A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Gro...
Status
Completed
Location
Andover Eye Associates
Start Date
2021-01-26
Trial ID
NCT04735393
The proposed 36-month Post Approval Efficacy Study (PAES) is a prospective,...
Status
Completed
Location
Fakultni Nemocnice Ostrava, Oční Klinika
Start Date
2019-05-31
Trial ID
NCT04144413
Treatments Being Tested
This pilot study evaluates the efficacy, safety, and tolerability of topica...
Status
Completed
Location
Multiple Locations
Start Date
2015-07-08
Trial ID
NCT07412587
The objective of this study is to identify the concentration and daily dosi...
Status
Completed
Location
Bausch & Lomb
Start Date
2010-07
Trial ID
NCT01163643
The investigators hypothesized that dornase alpha, administered twice a day...
Status
Completed
Location
University of Medicine and Dentistry of New Jersey
Start Date
2005-11
Trial ID
NCT01095276
Treatments Being Tested
This is a multicenter, open-label, dose escalation (Cohort 1) to masked, ra...
Status
Active Not Recruiting
Location
Horizon Eye Specialists & Lasik Center - Sun City /ID# 252153
Start Date
2020-11-16
Trial ID
NCT04499248
This is a Phase 2, multi-site, double-masked, randomized, vehicle-controlle...
Status
Completed
Location
GC2302 Study Site 110
Start Date
2025-11-03
Trial ID
NCT07264517
Treatments Being Tested